Kyoichi Kaira
- Biochemistry top 0.05%
- Amino Acid Enzymes and Metabolism 54
- Oncology top 0.5%
- Lung Cancer Research Studies 98
- Cancer Immunotherapy and Biomarkers 74
- Colorectal Cancer Treatments and Studies 31
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 142
- Lung Cancer Diagnosis and Treatment 64
- Cancer Research top 1%
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 43
-
- Neuroendocrine Tumor Research Advances 48
Kyoichi Kaira
413 papers receiving 9.0k citations
Peers
Comparison fields: 5 of 132
- Biochemistry 1.8k
- Oncology 4.3k
- Pulmonary and Respiratory Medicine 3.4k
- Cancer Research 1.5k
- Molecular Biology 3.3k
Countries citing papers authored by Kyoichi Kaira
This map shows the geographic impact of Kyoichi Kaira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyoichi Kaira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyoichi Kaira more than expected).
Fields of papers citing papers by Kyoichi Kaira
This network shows the impact of papers produced by Kyoichi Kaira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyoichi Kaira. The network helps show where Kyoichi Kaira may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kyoichi Kaira, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 7 | |
| 9 | 2022 | 27 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 1 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 1 | |
| 14 | 2020 | 13 | |
| 15 | 2019 | 169 | |
| 16 | 2019 | 4 | |
| 17 | 2019 | 5 | |
| 18 | 2017 | 15 | |
| 19 | 2015 | 11 | |
| 20 | 2011 | 135 |
About Kyoichi Kaira
Kyoichi Kaira is a scholar working on Oncology, Biochemistry and Pulmonary and Respiratory Medicine, having authored 425 papers that have together received 9.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (142 papers), Lung Cancer Research Studies (98 papers), Cancer Immunotherapy and Biomarkers (74 papers), Lung Cancer Diagnosis and Treatment (64 papers), Amino Acid Enzymes and Metabolism (54 papers), Neuroendocrine Tumor Research Advances (48 papers), Epigenetics and DNA Methylation (43 papers) and Colorectal Cancer Treatments and Studies (31 papers). The work is most often cited by research in Biochemistry (1.8k citations), Oncology (4.3k citations) and Pulmonary and Respiratory Medicine (3.4k citations). Kyoichi Kaira has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Noriaki Sunaga, Noboru Oriuchi, Kimihiro Shimizu, Hisao Imai, Yoshikatsu Kanai, Masatomo Mori, Tamotsu Ishizuka, Tetsunari Oyama, Takeshi Hisada and Noriko Yanagitani. Their work appears in journals such as Lung Cancer, Anticancer Research, Journal of Thoracic Oncology, Cancer Chemotherapy and Pharmacology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.